|Podcasts|December 23, 2021
Upcoming Podcast on ADHD Treatment Options
Author(s)Stephen V. Faraone, MD, PhD, Chris Aiken, MD
Advertisement
Stimulant medications have long been the mainstay of treatment for attention-deficit/hyperactivity disorder, but psychopharmacology is no longer the only game in town. Join us for a discussion on new nonpharmacological treatment approaches as Dr Chris Aiken, Psychiatric TimesTM Mood Disorders Section Editor and the Director of the Mood Treatment Center, talks with Dr Stephen Faraone, Distinguished Professor and Vice Chair of Research of Psychiatry and Behavioral Sciences at Upstate Medical University.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial: The Power of Another COMP360 Dose
2
The Postmodern Worldview and Contemporary Psychiatry
3
New Phase 2 Clinical Trial Initiating in 2027: Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
4
DT120 (Lysergide) ODT Receives Breakthrough Therapy Designation for Treatment of MDD
5





